Evidence map›Paper›PMID 31848164›Full record

ArticleBMJ open2019

Acupuncture for patients with cancer-induced xerostomia: a systematic review protocol.

Xixiu Ni, Yang Yu, Tian Tian, Lu Liu, Xiao Li, Fengmei Li, Yue Xu, Ling Zhao

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xixiu Ni *Acupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.ORCID 0000-0001-7359-6173
Yang Yu *Acupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.
Tian TianAcupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.
Lu LiuAcupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.
Xiao LiAcupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.
Fengmei LiAcupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China.
Yue XuHospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of TCM, Chengdu, Sichuan, China.
Ling ZhaoAcupuncture and Tuina School, Chengdu University of TCM, Chengdu, Sichuan, China zhaoling@cdutcm.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionXerostomia is a common symptom in patients with cancer. Currently available methods to manage xerostomia include stringent oral hygiene using fluoride agents and antimicrobials, saliva substitutes and sialagogic agents, but side effects such as headache, dizziness and sweating can occur with these therapies. Clinical trials have shown that acupuncture may be effective in treating xerostomia. The objective of this systematic review is to assess the effectiveness and safety of acupuncture treatment for xerostomia caused by cancer. METHODS AND ANALYSIS: This systematic review will incorporate articles identified by electronically searching the following databases: PubMed, MEDLINE, the Cochrane Library, AMED, EMbase, WorldSciNet, Nature, Science Online, China National Knowledge Infrastructure, the Chongqing VIP Chinese Science and Technology Periodical Database, the Wanfang Database and China Biology Medicine Disc from inception to 1 December 2019. Other sources including conference proceedings and reference lists of identified publications and existing systematic reviews will also be searched. Two reviewers will independently search the databases, perform data extraction and assess the quality of studies. Data will be synthesised using either a fixed-effects model or a random-effects model, according to heterogeneity testing. Patient-reported change in the Visual Analogue Scale or the Xerostomia Inventory will be assessed as the primary outcome. Saliva collection, whole saliva production and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 will be evaluated as secondary outcomes. RevMan V. 5.3 will be employed for data analysis. The results will be expressed as risk ratios for dichotomous data and mean differences for continuous data. ETHICS AND DISSEMINATION: This protocol will not evaluate individual patient information or affect patient rights and therefore does not require ethical approval. Results from this review will be disseminated through peer-reviewed journals and conference reports. TRIAL REGISTRATION NUMBER: CRD42019129069.

Indexed as

Acupuncture TherapyHumansNeoplasmsRandomized Controlled Trials as TopicSystematic Reviews as TopicXerostomiaacupuncturecancersystematic reviewxerostomia

Identifiers

PMID31848164
PMCPMC6936981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.